ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date

Monday, November 9, 2015

9:00AM-11:00AM
Abstract Number: 1332
Assessing Radiographic Damage in Ankylosing Spondylitis: Variability in Reliability of the Modified Stoke Ankylosing Spondylitis Spine Score According to the Statistical Method
Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT
9:00AM-11:00AM
Abstract Number: 1226
Assessing the Possible Association of Anti-TNF Use with New Neoplasms: An Important Methodological Consideration
Epidemiology and Public Health Poster II: Pathogenesis and Treatment of Systemic Inflammatory Diseases
9:00AM-11:00AM
Abstract Number: 1738
Assessing the Validity of the Multi-Biomarker Disease Activity Assay in Patients with Psoriatic Arthritis
Spondylarthropathies and Psoriatic Arthritis - Comorbidities and Treatment Poster II
9:00AM-11:00AM
Abstract Number: 1320
Assessment of 18F-Fluoro-Deoxyglucose Uptake in the Ascending Aorta of Rheumatoid Arthritis Patients
Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT
9:00AM-11:00AM
Abstract Number: 1185
Assessment of a Rheumatology Curriculum Utilizing Multiple Learning Modalities
Education Poster I
9:00AM-11:00AM
Abstract Number: 1333
Assessment of Focal Fat Infiltration in Sacroiliac Joints in Patients with Spondyloarthritis By 1.5T Versus 3.0T Magnetic Resonance Imaging: Is the Field Strength Important to Contrast to Noise Ratios, Reproducibility and Total Scores?
Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT
9:00AM-11:00AM
Abstract Number: 1464
Assessment of Left Ventricle Functions in Children with Familial Mediterranean Fever with Tissue Doppler and Strain Echocardiography
Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases
9:00AM-11:00AM
Abstract Number: 1903
Assessment of Subclinical Atherosclerosis in Patients with Systemic Sclerosis: Results from a Multicentric Cohort
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster II
9:00AM-11:00AM
Abstract Number: 1466
Assessment of Transition Readiness in Adolescents and Young Adults with Chronic Health Conditions
Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases
9:00AM-11:00AM
Abstract Number: 1865
Association Between Changes in Expression of Gene Signatures and Disease Activity Among Patients with Systemic Lupus Erythematosus
Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 1852
Association of Antibodies to the NR1 Subunit of N-Methyl-D-Aspartate Receptors with Neuropsychiatric Systemic Lupus Erythematosus
Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 1458
Association of Chronic, Extreme Elevation of Serum IL-18 with the Development of Macrophage Activation Syndrome in a Cohort of Autoinflammatory Disease Patients: A Potential Diagnostic Biomarker?
Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases
9:00AM-11:00AM
Abstract Number: 1869
Association of CLEC16A with SLE in a Large Multi-Ancestry Cohort and Implication in B-Cell Receptor Signaling
Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 1883
Association of Myocardial Abnormalities with  Disease Characteristic and Brain Natriuretic Peptide (BNP) in Systemic Sclerosis without Cardiac Symptoms As Assessed Using Cardiac Magnetic Resonance Imaging; A Prospective Multi Center Study
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster II
9:00AM-11:00AM
Abstract Number: 1579
Association of Myocardial Abnormalities with N-Terminal Pro-Brain Natriuretic Peptide and Disease Activity in Rheumatoid Arthritis without Cardiac Symptoms, Assessed By Cardiac Magnetic Resonance Imaging
Rheumatoid Arthritis - Clinical Aspects Poster II
  • «Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 72
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology